Dodick, D. W., Tepper, S. J., Friedman, D. I., Gelfand, A. A., Kellerman, D. J., & Schmidt, P. C. (2018). Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. Headache.
Stile di citazione ChicagoDodick, David W., Stewart J. Tepper, Deborah I. Friedman, Amy A. Gelfand, Donald J. Kellerman, e Peter C. Schmidt. "Use of Most Bothersome Symptom As a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial." Headache 2018.
Citazione MLADodick, David W., et al. "Use of Most Bothersome Symptom As a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial." Headache 2018.